Delivery Order SPE2DB20D3101-SPE2DB23FRYR1

Award Date 9/22/23
Potential Completion Date 9/25/23
Potential Value $20K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management, to the Defense Logistics Agency (DLA). The $1,959.48 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,610.97 and a completion date of December 17, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a pharmaceutical product used in the treatment of diabetes. The contract, valued at $35,223.56, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml, a medication used to manage diabetes. The award, valued at $6,966.24, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $3,262.56 and a completion date of November 21, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract has a ceiling value of $1,091.88 and a performance period through January 31, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc. The contract was awarded as a firm fixed-price...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, which are used to manage diabetes. The $4,547.82 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,879.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as a Firm Fixed Price Delivery Order with a ceiling value of $7,571.86. The award has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,122.14, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that provides a wide range of medical supplies to various government agencies. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYR1
    Delivery Order

This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,875.89, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:39 AM